In a groundbreaking story MindMed (MNMD.Q) announced today has been granted approval by the Swiss Ethics Committee to evaluate the acute effects of different doses of mescaline and the…
Taylor Gavinchuk
They seem to have been born that way. They are naturally incapable of grasping and developing a manner of living which demands rigorous honesty. Today Alcoholics Anonymous (AA) is…
Survivors of childhood trauma Everyone’s therapy journey is different. Some people can move past what they are dealing with purely through talk therapy. By understanding on a logical level…
Esketamine Braxia Scientific (BRAX.C), formerly known as Champignon Brands had a rough 2020. It was a down year for many of us, but Champignon really found itself in trouble…
Serotonin over psychedelics Bright Minds Biosciences (DRUG.C) isn’t banking on recreational psychedelics being relevant any time soon, they aren’t selling mushroom powder, and don’t own any ketamine clinics. Rather,…
Phase 3 Today MAPS released the results of its highly anticipated phase 3 MDMA assisted therapy for severe PTSD study. The results are what many, including myself, anticipated –…
Brain trauma/CTE Lobe Sciences (LOBE.C) is working to develop effective psychedelic-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder with a focus on contact…
“Say something, goddammit! You are on television! You’re live to the whole world!” – The Truman Show After multiple attempts at writing a story on HAVN Life Sciences (HAVN.C)…
Last week Cybin (CYBN.NE) announced it was targetting alcoholism with its novel psychedelic compound CYB003. Another EG staffer wrote a piece last Monday outlining the details of the plan,…
PFN Program Tryp Therapeutics (TRYP.C) is a Kelowna-based psychedelics company looking to improve the lives of those with fibromyalgia, hyperphagia, and eating disorders. In the company’s young life so…